Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
BAX · NYSE · Healthcare
Fundamental quality
36
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its growth weighs in its favor, while its profitability drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | $12,146M | $1,284M | $1,531M | $14,803M |
| 2022 | $10,057M | -$2,433M | $834M | $15,081M |
| 2023 | $10,360M | $2,656M | $1,294M | $10,777M |
| 2024 | $10,636M | -$649M | $573M | $11,416M |
| 2025 | $11,244M | -$957M | $332M | $7,472M |
Between 2021 and 2025, revenue went from $12,146M to $11,244M (-7%) and net income went from $1,284M to -$957M (-175%).
Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.
Is Baxter International Inc a profitable company?
Over the last twelve months, no: Baxter International Inc posts a negative net margin (-9.7%).
Does Baxter International Inc have a lot of debt?
Yes, its leverage is high: net debt is 11.06 times its EBITDA.
Is Baxter International Inc growing?
Its revenue has grown 3.7% annualized in recent years.
Does Baxter International Inc generate cash?
Yes. It converts about 6.5% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Baxter International Inc cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →